Book contents
- Frontmatter
- Contents
- Figures
- Tables
- Contributors
- Acknowledgements
- Abbreviations and acronyms
- Foreword
- Introduction
- Part I The research
- 1 Sexual transmission of HIV
- 2 Prevention of non-sexual transmission of HIV
- 3 Treatment
- 4 Strengthening health systems
- 5 Social policy
- 6 Vaccine research and development
- Part II Ranking the opportunities
- Index
- References
4 - Strengthening health systems
Assessment paper
Published online by Cambridge University Press: 05 November 2012
Edited by
Book contents
- Frontmatter
- Contents
- Figures
- Tables
- Contributors
- Acknowledgements
- Abbreviations and acronyms
- Foreword
- Introduction
- Part I The research
- 1 Sexual transmission of HIV
- 2 Prevention of non-sexual transmission of HIV
- 3 Treatment
- 4 Strengthening health systems
- 5 Social policy
- 6 Vaccine research and development
- Part II Ranking the opportunities
- Index
- References
Summary
Executive summary
RethinkHIV seeks answers to the question: “How can additional spending, $2 billion per annum over five years, a total of $10 billion, best be spent across a range of treatment, prevention, research, etc., measures in sub-Saharan Africa (SSA) to respond to HIV/AIDS?” Among the prospective options is an effective bridging between actions focused specifically on HIV/AIDS, and actions that aim to strengthen health systems. The strengthening health systems component considers below these possible solutions:
Universal testing, informing, and counseling can be achieved with a voucher of $5 paid to each of the 400 million adults who accept to learn their HIV status. The cost is substantial at $2 billion, but benefits of knowledge could cut new infections by a quarter million annually, and the B/C ratio would range between a low of 2.5 and a high of 15.
Deployment of community health workers to the rural population at a cost of $2.64 billion could cut maternal deaths by 0.3 million annually and child deaths by millions more, with B/C ratios ranging from about 1.1 to 9.5.
Reducing the opportunistic infection of cryptococcal meningitis (CM) at a cost of $1.5 billion can yield a ratio of benefits to costs between 2.7 and 20.
An Abuja Goals Fund (AGF) can offer a cash on delivery (COD) incentive for meeting-agreed goals of spending 15 percent or more of public revenues on public health, yielding a ratio of benefits to cost between 1.1 and 8.
The analysis of these solutions applies cost-benefit analysis (CBA) to provide guidance for resource allocation at the margin between these and other potential solutions to health deficiencies in SSA. Each of the solutions reviewed offers positive returns of benefits compared to the incremental costs that would be incurred to implement them (see Table 4.1). The analysis considers scenarios in which the value of a year of life is set at $1,000 or $5,000 to include the range of income levels in SSA. The net present value (NPV) of future years of life is assessed using both a 3 percent and a 5 percent discount rate. Once these values for a life-year are adjusted to yield net present values of all the years of life that can be saved by a solution, we calculate the ratio of these two measures of benefits to the costs identified.
- Type
- Chapter
- Information
- RethinkHIVSmarter Ways to Invest in Ending HIV in Sub-Saharan Africa, pp. 183 - 237Publisher: Cambridge University PressPrint publication year: 2012
References
2005 Committing to Results: Improving the Effectiveness of HIV/AIDS Assistance. An OED Evaluation of the World Bank's Assistance for HIV/AIDS ControlWashington DCWorld Bankwww.worldbank.org/oed/aids/docs/report/hiv%5Fcomplete%5Freport.pdfCrossRefGoogle Scholar
2010 HIV spending as a share of total health expenditure: an analysis of regional variation in a multi-country studyPLoS One 5CrossRefGoogle Scholar
2009 HIV and AIDS Programs: How they Support Health System StrengtheningWashington DCResults for Development InstituteGoogle Scholar
2010 Post-Crisis AIDS Financing: Smarter Choices, Integration and EfficiencyGenevaUNAIDSGoogle Scholar
2009 The Short Term Impacts of a Schooling Conditional Cash Transfer Program on the Sexual Behavior of Young WomenWashington DCWorld BankCrossRefGoogle Scholar
2011 Poor Economics, a Radical Rethinking of the Way to Fight Global PovertyNew YorkPublic AffairsGoogle Scholar
2006
2001 Economic Analysis of Investment Operations: Analytical Tools and Practical ApplicationsWashington DCWorld Bank, WBI Development StudiesGoogle Scholar
2009 The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS controlHealth Policy Plan 24 239CrossRefGoogle ScholarPubMed
2010 Cash on Delivery: A New Approach to Foreign Aid, with an Application to Primary SchoolingBaltimore, MDBrookings Institution PressGoogle Scholar
2011 Feasibility, diagnostic accuracy, and effectiveness of decentralized use of the Xpert MTG/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet 377 1495CrossRefGoogle Scholar
2009 A response to critics of family planning programsInternational Perspectives on Sexual and Reproductive Health 35 40CrossRefGoogle ScholarPubMed
2010 Costs and Benefits Study of the NHIS/MDG Maternal and Child Health ProjectWashington DCFutures GroupGoogle Scholar
2006 The economics of HIV/AIDS in low-income countries: the case for preventionJournal of Economic Perspectives 20 121CrossRefGoogle Scholar
2011 One Million Community Health Workers: Technical Task Force ReportNew YorkThe Earth Institute, Columbia UniversityGoogle Scholar
2008 Are we finally winning the war on cancer?Journal of Economic Perspectives 22 3CrossRefGoogle ScholarPubMed
2005 The role of public health improvements in health advancesDemography 42 1CrossRefGoogle ScholarPubMed
1995 Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short periodClin Infect Dis 20 263CrossRefGoogle Scholar
www.doh.gov.za/
2010 Examining the promise of HIV elimination by “test and treat” in hyperendemic settingsAIDS 24 729CrossRefGoogle Scholar
2008 Major role for amphotericin B-flucytosine combination in severe cryptococcosisPLoS One 3CrossRefGoogle ScholarPubMed
2010
2010 www.nber.org/papers/w14707
2008 Health Systems Strengthening Via Performance-Based Aid: Creating Incentives to Perform and to Measure ResultsBaltimore, MDBrookings InstitutionGoogle Scholar
2009 Performance Incentives for Global Health: Potential and PitfallsBaltimore, MDBrookings Institution PressGoogle Scholar
2007 The Invisible Cure: Africa, The West, and the Fight Against AIDSNew YorkFarrar, Strauss and GirouxGoogle Scholar
2011
2009 10-year effect of Oportunidades, Mexico's conditional cash transfer programme, on child growth, cognition, language, and behaviour: a longitudinal follow-up studyThe Lancet 374 1997CrossRefGoogle ScholarPubMed
2000 Weak links in the chain: a diagnosis of health policy in poor countriesThe World Bank Research Observer 15 199CrossRefGoogle Scholar
2002 Weak links in the chain II: a prescription for health policy in poor countriesThe World Bank Research Observer 17 47CrossRefGoogle Scholar
1999 The impact of public spending on health: does money matter?Social Science and Medicine 49 1309CrossRefGoogle ScholarPubMed
2009 Conditional Cash Transfers: Reducing Present and Future PovertyWashington DCWorld BankCrossRefGoogle Scholar
2001 Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysisHealth Policy and Planning 16 326CrossRefGoogle Scholar
2009 Treating our way out of the HIV pandemic: could we, would we, should we?Lancet 373 9CrossRefGoogle Scholar
2011 The health systems funding platform: resolving tensions between the aid and development effectiveness agendasWashington DCCenter for Global DevelopmentGoogle Scholar
2011
2008 Good Practices in Health Financing: Lessons From Reforms in Low- and Middle-Income CountriesWashington DCWorld BankCrossRefGoogle Scholar
2009 Protecting Pro-Poor Health Services During Financing Crises, Lessons From ExperienceWashington DCWorld BankGoogle ScholarPubMed
2009 Happiness Around the world: The Paradox of Happy Peasants and Miserable MillionairesOxford University PressCrossRefGoogle Scholar
2008 Universal voluntary HIV testing with immediate anti-retroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet onlineGoogle ScholarPubMed
2010 The Long Run Costs and Financing of HIV/AIDS in South AfricaWashington DCResults for Development InstituteGoogle Scholar
2010 Costs and Choices: Financing the Long-Term Fight against AIDSWashington DCResults for Development InstituteGoogle Scholar
2010 Critical choices in financing the response to the global HIV/AIDS pandemicHealth Affairs 28 1Google Scholar
2009
2008 Update
2008
2009
2009
2009 www.internationalhealthpartnership.net/ihp_plus_documents.html
2009
www.internationalhealthpartnership.net/ihp_plus_about_objectives.html
2011 IHP+ Results: Strengthening Accountability to Achieve the Health MDGs. Annual Performance Report 2010LondonResponsible Action UKGoogle Scholar
2010 Disease controlSmart Solutions To Climate Change: Comparing Costs and BenefitsCambridge University PressGoogle Scholar
2006 Disease Control Priorities in Developing CountriesWashington DCWorld Bank and Oxford University PressGoogle ScholarPubMed
2009 Screening for cryptococcal antigenemia in patients accessing an anti-retroviral treatment program in South AfricaClin Infect Dis 48 856CrossRefGoogle Scholar
2011 How effective are family-planning programs at improving the lives of women?Some perspectives from a vast literatureWashington DCGeorgetown UniversityGoogle Scholar
2011 More than Good Intentions: How a New Economics is Helping to Solve Global PovertyNew YorkDuttonGoogle Scholar
2011 Getting Better: Why Global Development Is Succeeding – and How We Can Improve the World Even MoreNew YorkBasic BooksGoogle Scholar
2011 Improving tuberculosis diagnostics and treatmentThe Lancet 377 1467CrossRefGoogle ScholarPubMed
2006 Progress against Poverty: Sustaining Mexico's Progresa-Oportunidades ProgramWashington DCBrookings Institution PressGoogle Scholar
2006 How to Spend $50 Billion to Make the World a Better PlaceCambridge University PressCrossRefGoogle Scholar
2007 Solutions for the World's Biggest Problems: Costs and BenefitsCambridge University PressCrossRefGoogle Scholar
2010 Public financing of health in developing countries: a cross-national systematic analysisLancet 375 1375CrossRefGoogle ScholarPubMed
2009 The Changing HIV/AIDS Landscape: Selected Papers for the World Bank's Agenda for Action in Africa, 2007–2011Washington DCWorld BankCrossRefGoogle Scholar
2009 Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major RisksGenevaWHOGoogle Scholar
2010 Taskforce on innovative international financing for health systems: what next?Bulletin of the World Health Organization 88 478CrossRefGoogle ScholarPubMed
2009
2007 Economic rate of return report: economic analysis of the Lesotho health projectMimeoMarchGoogle Scholar
2010
2010
2011
2008 Potential Application of Conditional Cash Transfers for Prevention of Sexually Transmitted Infections and HIV in Sub-Saharan AfricaWashington DCWorld Bank Policy Research Working Paper No.CrossRefGoogle Scholar
2010 Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsClin Infect Dis 51 448CrossRefGoogle ScholarPubMed
2010 Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in CambodiaPLoS One 5CrossRefGoogle ScholarPubMed
2011 The Haves and the Have-Nots, a Brief and Idiosyncratic History of Global InequalityNew YorkBasic BooksGoogle Scholar
2009 Constraints to Scaling Up and Costs. Working Group ReportTaskforce on innovative international financing for health systemsGoogle Scholar
2007 Communicable diseases 2006 How to Spend $50 Billion to Make the World a Better PlaceCambridge University Press19Google Scholar
2000 Voices of the Poor, Crying Out for ChangeWashington DCOxford University Press for World BankCrossRefGoogle Scholar
2003 The health of nations: the contribution of improved health to living standardsMeasuring the Gains from Medical Research: An Economic ApproachUniversity of Chicago PressGoogle Scholar
2011
2008 The “diagonal” approach to Global Fund financing: a cure for the broader malaise of health systems?Globalization and Health 4 6Google Scholar
2008 Prevention Failure: The Ballooning Entitlement Burden of U.S. Global AIDS Treatment Spending and What to Do about ItWashington DCCenter for Global DevelopmentGoogle Scholar
2010 Using Incentives to Prevent HIV InfectionsWashington DCCenter for Global DevelopmentGoogle Scholar
2009 Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSAIDS 2009 23 525Google ScholarPubMed
2010 Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of AmericaClin Infect Dis 50 291CrossRefGoogle ScholarPubMed
2009
2005 Additionality: Dimensions, Issues and Indicators. Measuring the Systems Effect of the Global Fund with a Focus on Additionality, Partnerships, and SustainabilityGenevaThe Global FundGoogle Scholar
2011 Cost-effectiveness of cryptococcal antigen screening of at-risk HIV/AIDS patients in South Africa in order to save lives associated with human cryptococcosis. DraftLondonLSHTMGoogle Scholar
2009 Strengthening health systems: the role of supply chains in addressing the HIV epidemic 2009 The Changing HIV/AIDS Landscape: Selected Papers for the World Bank's Agenda for Action in Africa, 2007–2011Washington DCWorld Bank411Google Scholar
2010 Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania – a prospective cost-effectiveness studyJaids – Journal of Acquired Immune Deficiency Syndromes 55 397CrossRefGoogle ScholarPubMed
2004 Getting Health Reform Right: A Guide to Improving Performance and EquityNew YorkOxford University PressGoogle Scholar
1997 The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patientsMed Decis Making 17 373CrossRefGoogle ScholarPubMed
2011
2005
2009 Cost-effectiveness in low- and middle-income countries: a review of the debates surrounding decision rulesPharmacoeconomics 27 903CrossRefGoogle ScholarPubMed
2009 Treatment of cryptococcal meningitis in resource limited settingsCurr Opin Infect Dis 22 455CrossRefGoogle ScholarPubMed
2009 Development assistance for health: some recent trends and implicationsWashington DCWorld BankGoogle Scholar
2011 89
2011
2005 The Demand for and Impact of Learning HIV Status: Evidence from a Field ExperimentSouthern African Regional Poverty NetworkGoogle Scholar
2003 The value of a statistical life: a critical review of market estimates throughout the worldThe Journal of Risk and Uncertainty 27 5CrossRefGoogle Scholar
2010 Cost-Benefit Analysis in World Bank ProjectsWashington DCIndependent Evaluation Group, World BankGoogle Scholar
2007 Everybody's Business: Strengthening Health Systems to Improve Health Outcomes. WHO's Framework for ActionGenevaWorld Health OrganizationGoogle Scholar